Mechanistically, via activation of the PI3K/Akt/PKCα–pathway, C2CD4B promotes oxidative stress–dependent endothelial dysfunction, driving eNOS uncoupling and NADPH oxidase dysregulation. Here, FMO5 is linked to endothelial dysfunction.